SCHEDULE 13D Filed 2026-05-01 Event 2026-04-21 SEC 0001493152-26-020941 →

LoPriore Vincent S → Hepion Pharmaceuticals, Inc. CTRVP

Stake: 21.46% Shares: 5,000,000 CUSIP: 426897401 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

The Common Stock owned by each of the Reporting Persons has been acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

Cross-References

Insider Activity (last 365d)

12 transactions

12 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Post-Filing Returns · since 2026-04-21 on CTRVP

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

—

Anchor price 0.00 on closest trading day on/after 2026-04-21. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-03	Stetz Gary S. II	director	Buy	500,000	$0.05	$25K
2026-08-03	Stetz Gary S. II	director	Buy	500,000	$0.06	$30K
2026-08-03	Stetz Gary S.	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	Stetz Gary S.	director, officer	Buy	2,000,000	$0.06	$120K
2026-08-03	Purcell Michael J.	director	Buy	2,000,000	$0.05	$100K
2026-08-03	Purcell Michael J.	director	Buy	2,000,000	$0.06	$120K
2026-08-03	Appajosyula Sireesh	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	Appajosyula Sireesh	director, officer	Buy	2,000,000	$0.06	$120K
2026-08-03	LoPriore Vincent S	director, officer	Buy	8,000,000	$0.05	$400K
2026-08-03	LoPriore Vincent S	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	LoPriore Vincent S	director, officer	Buy	8,000,000	$0.06	$480K
2026-08-03	LoPriore Vincent S	director, officer	Buy	2,000,000	$0.06	$120K

Other 13D/G Filings on Hepion Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-07	SCHEDULE 13D	Black Global 5 LLC	11.10%	10,000,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →